Ardent Health (NYSE:ARDT) Shares Gap Down on Disappointing Earnings

Ardent Health, Inc. (NYSE:ARDT)’s share price gapped down prior to trading on Thursday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $9.64, but opened at $8.62. Ardent Health shares last traded at $9.41, with a volume of 323,257 shares trading hands.

The company reported $0.32 EPS for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.03). Ardent Health had a net margin of 2.15% and a return on equity of 14.46%. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.63 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS.

More Ardent Health News

Here are the key news stories impacting Ardent Health this week:

• Positive Sentiment: Management outlined a $485M–$535M 2026 EBITDA target driven by an “impact” savings program and expansion of AI‑driven care — a structural cost initiative that could materially improve margins if delivered. Article Title
• Neutral Sentiment: Earnings call transcript and slide deck are available for investors to review management’s execution plans and modeling assumptions; these provide detail but do not change the immediate headline drivers. Earnings Call Transcript Slide Deck
• Negative Sentiment: Q4 results missed consensus (EPS $0.32 vs $0.35 est.; revenue $1.61B vs $1.63B est.), and the company cut FY‑2026 EPS guidance to $0.90–$1.27 versus the street ~$1.40 — a clear near‑term catalyst for downward revisions to models and analyst estimates. Earnings Summary
• Negative Sentiment: Multiple law firms have filed or solicited clients for securities class actions tied to November 2025 collectability/reserve disclosures (alleged “180‑day cliff” and ~$97M impact). The proliferation of notices and lead‑plaintiff deadlines raises legal risk, potential settlements, and continued headline volatility. Hagens Berman Notice Rosen Law Notice

Wall Street Analyst Weigh In

ARDT has been the topic of several research reports. Stephens reduced their price target on Ardent Health from $21.00 to $17.00 and set an “overweight” rating on the stock in a report on Friday, November 14th. Royal Bank Of Canada cut their target price on shares of Ardent Health from $21.00 to $16.00 and set an “outperform” rating on the stock in a research report on Friday, November 14th. Bank of America reduced their target price on shares of Ardent Health from $12.00 to $10.00 and set an “underperform” rating on the stock in a report on Thursday, November 13th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Ardent Health in a research note on Monday, December 29th. Finally, Leerink Partners set a $16.00 price target on shares of Ardent Health in a report on Friday, November 14th. Six analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $14.58.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Goldentree Asset Management LP increased its position in shares of Ardent Health by 99.7% during the fourth quarter. Goldentree Asset Management LP now owns 2,303,113 shares of the company’s stock worth $20,302,000 after buying an additional 1,150,000 shares during the period. Ameriprise Financial Inc. lifted its holdings in Ardent Health by 8.2% in the third quarter. Ameriprise Financial Inc. now owns 1,769,335 shares of the company’s stock valued at $23,444,000 after buying an additional 134,513 shares during the period. Vanguard Group Inc. boosted its position in Ardent Health by 44.5% during the third quarter. Vanguard Group Inc. now owns 1,352,676 shares of the company’s stock valued at $17,923,000 after acquiring an additional 416,348 shares during the last quarter. Millennium Management LLC grew its holdings in Ardent Health by 6.6% during the 3rd quarter. Millennium Management LLC now owns 1,269,605 shares of the company’s stock worth $16,822,000 after acquiring an additional 78,861 shares during the period. Finally, Bridgeway Capital Management LLC grew its holdings in Ardent Health by 108.2% during the 4th quarter. Bridgeway Capital Management LLC now owns 946,571 shares of the company’s stock worth $8,358,000 after acquiring an additional 491,961 shares during the period.

Ardent Health Stock Performance

The stock has a market capitalization of $1.35 billion, a P/E ratio of 9.83, a price-to-earnings-growth ratio of 5.31 and a beta of 0.46. The company has a current ratio of 2.08, a quick ratio of 1.95 and a debt-to-equity ratio of 0.67. The company has a 50-day moving average price of $9.01 and a two-hundred day moving average price of $11.03.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.